Neurotechnology Market Report 2026

Neurotechnology Market Overview

• Neurotechnology market size has reached to $17.34 billion in 2025 • Expected to grow to $33.64 billion in 2030 at a compound annual growth rate (CAGR) of 14.1% • Growth Driver: Neurological Conditions' Surge Catalyst For Neurotechnology Market Expansion • Market Trend: Revolutionary Solutions Enhance Mobility And Cognitive Function In Neurological Care • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Neurotechnology Market?

Neurotechnology is the study and interaction of the nervous system, which includes the brain and other parts of the nervous system. Neurotechnology can be used in clinical settings to influence the brain or nervous system, such as in therapeutic or rehabilitative contexts. Recent advancements in neurotechnology have shown promise in treating neurological disorders and enhancing cognitive function, making it a vital area of research and application. The main neurotechnology conditions are cognitive disorders, pain treatment, urinary and faecal incontinence, epilepsy, Parkinson's disease, hearing conditions, sleep disorder, depression, and others. Cognitive disorders refer to a significant decline in an individual's cognitive function, to an extent that without treatment, it becomes challenging to perform regular social activities. The various types are imaging modalities, neurostimulation, cranial surface measurement, neurological implants, and others used by ambulatory surgical centers, hospitals, homecare facilities, and others.

What Is The Neurotechnology Market Growth Forecast?

The neurotechnology market size is expected to see rapid growth in the next few years. It will grow to $33.64 billion in 2030 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to growing investment in brain-computer interfaces, increasing demand for personalized neurological treatments, expanding use of ai-driven diagnostics, rising adoption of home-based neurotechnology, development of minimally invasive neurotherapies. Major trends in the forecast period include expansion of brain-computer interface solutions, rising adoption of non-invasive neurostimulation devices, increasing integration of neuroimaging in clinical diagnostics, growing demand for cognitive rehabilitation technologies, advancement in neurological implant materials.

Global Neurotechnology Market Segmentation

1) By Conditions: Cognitive Disorders, Pain Treatment, Urinary And Fecal Incontinence, Epilepsy, Parkinson's Disease, Hearing Conditions, Sleep Disorder, Depression, Other Conditions 2) By Type: Imaging Modalities, Neurostimulation, Cranial Surface Measurement, Neurological Implants, Other Types 3) By End Use: Ambulatory Surgical Centers, Hospitals, Homecare Facilities, Other End Uses Subsegments: 1) By Cognitive Disorders: Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Dementia 2) By Pain Treatment: Chronic Pain, Neuropathic Pain, Acute Pain 3) By Urinary And Fecal Incontinence: Overactive Bladder, Neurogenic Bladder, Fecal Incontinence Management 4) By Epilepsy: Drug-Resistant Epilepsy, Seizure Management Devices 5) By Parkinson's Disease: Motor Symptoms Management, Non-Motor Symptoms Management 6) By Hearing Conditions: Tinnitus, Hearing Loss Solutions 7) By Sleep Disorder: Insomnia, Sleep Apnea, Restless Legs Syndrome 8) By Depression: Major Depressive Disorder, Treatment-Resistant Depression 9) By Other Conditions: Anxiety Disorders, Autism Spectrum Disorder, Traumatic Brain Injury (TBI)

What Is The Driver Of The Neurotechnology Market?

The increased prevalence of neurological conditions is expected to propel the growth of the neurotechnology market going forward. A neurological condition is any disorder or disease that affects the brain, common neurological conditions include Alzheimer's disease, Parkinson's disease, epilepsy, and migraine. Neurotechnology is being used to diagnose and treat neurological disorders in a variety of ways, including brain imaging, neurostimulation, neurofeedback, and brain-computer interfaces. For instance, in October 2023, according to the World Federation of Neurology, a UK-based charity, reflecting an accelerating global health burden, neurological disorders now represent the second-leading cause of death and the primary cause of disability worldwide, with more than 40 percent of the global population affected in 2023 and the number of individuals living with brain disease projected to nearly double by 2050. Therefore, the increased prevalence of neurological conditions is driving the growth of the neurotechnology industry going forward.

Key Players In The Global Neurotechnology Market

Major companies operating in the neurotechnology market are General Electric, Medtronic PLC, Koninklijke Philips N.V., Shimadzu Corporation, Elekta AB, Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., Neurotech Pharmaceuticals Inc., Neuralink, Synchron Inc., Blackrock Neurotech, Neuronetics Inc., Neurable Inc.

Global Neurotechnology Market Trends and Insights

Major companies in the neurotechnology market are focused on developing advanced therapeutic solutions such as the endovascular brain-computer interface (BCI) to enhance cognitive function and restore mobility for patients with neurological impairments. The endovascular brain-computer interface (BCI) facilitates direct neural access through blood vessels, allowing for improved interaction and treatment options for patients with neurological disorders. For instance, in April 2024, Synchron's, a Sweden-based software company focused on developing advanced synchronization technologies for seamless data integration and management, launched Patient Registry for Stentrode Brain Computer Interface. The Synchron Stentrode BCI technology is designed to interpret brain signals and restore motor intent, allowing individuals with limited mobility to control digital devices hands-free. Implanted through a non-invasive endovascular procedure, it wirelessly transmits motor intent from the brain, enabling severely paralyzed patients to regain independence. This ground-breaking technology represents a significant advancement in assistive solutions, improving daily activities such as communication and accessing essential services.

What Are Latest Mergers And Acquisitions In The Neurotechnology Market?

In May 2025, electroCore, a US-based provider of non-invasive bioelectronic and neuromodulation therapies, acquired NeuroMetrix for an undisclosed amount. With this acquisition, electroCore aims to broaden its neurotechnology portfolio and accelerate commercial expansion by integrating NeuroMetrix’s cloud-enabled wearable neuromodulation platform to strengthen its position in chronic pain management. NeuroMetrix is a US-based provider of neurotechnology solutions, including app-connected wearable neuromodulation devices for fibromyalgia and chronic pain alongside diagnostic tools for neuropathic conditions.

Regional Outlook

North America was the largest region in the neurotechnology market in 2025. Europe is expected to be the fastest-growing region in the neurotechnology market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurotechnology Market?

The neurotechnology market includes revenues earned by entities from neuro-rehabilitative treatment, heart rate variability, electroencephalography, and neurostimulation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The neurotechnology market consists of sales of brain-computer interfaces (BCIs), neurostimulation devices, virtual reality (VR), and prosthetic limb devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neurotechnology Market Report 2026?

The neurotechnology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neurotechnology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.